IP Verse

Sanofi vs. Zentiva - UPC_CFI_148/2024

The case UPC_CFI_148/2024 was filed by the plaintiff Sanofi against the defendant Zentiva on 13 May, 2024.

Case Timeline

13 May, 2024
Case Filed
02 Sep, 2024
Counterclaim for Revocation
10 Sep, 2025
Written Procedure
10 Sep, 2025
Interim Conference
10 Sep, 2025
Oral Procedure
Today Nov 1, 2025
Decision

Case Details

    Case Number:

    UPC_CFI_148/2024

    Patent Number:

    EP2493466

    Filing Date:

    13 May, 2024

    Proceeding Type:

    Infringement

    Case Phase:

    Oral Phase

    Plaintiffs:

    • Sanofi
    • Sanofi AB
    • Sanofi Aventis
    • Sanofi Aventis Deutschland
    • Sanofi Aventis France
    • Sanofi Belgium
    • Sanofi Mature
    • Sanofi Produtos Farmaceuticos LDA
    • Sanofi Winthrop Industrie

    Plaintiff Representative:

    • Frédéric CHEVALLIER

    Defendants:

    • Zentiva
    • Zentiva France
    • Zentiva Pharma

    Defendant Representative:

    • Anja Lunze

    Judges:

    • Alima Zana
    • Carola Wagner
    • Matthias Zigann
    • Tobias Pichlmaier

    Court Division:

    First Instance, Local Division - Munich

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Sep 15, 2025Summons Party Expert Witnesses
Sep 15, 2025Summon Oral Hearing
Sep 15, 2025R 105.5 2Nd Interim Conference 12 Sep.
Sep 15, 2025Oral Hearing Reference Ic
Sep 15, 2025Interim Procedure Closure
Sep 15, 2025Hearing Dates
Sep 15, 2025Headnote And Keywords
Sep 10, 2025Written Procedure Closure
Sep 10, 2025Interim Conference Decision
Sep 10, 2025Fix Interim Conference Date
Sep 2, 2025Receipt
Sep 1, 2025Dfmp 119 Copy Of The Epo Tba Communication On Issuance Of Written Decision Of 18 August 2025
Sep 1, 2025Dfmp 118 Overview Document Evidencing The Relevant Facts As Well As Reference To The Most Important Citation Therein
Sep 1, 2025Application
Sep 1, 202509 01 Sanofi VS. Zentiva Zentiva Application R. 176 Rop R. 9 Rop Pdfa
Aug 11, 2025Receipt
Aug 8, 2025Exhibit Dfmp D117 Expert Opinion Of Prof Mueller
Aug 8, 2025Exhibit Dfmp D116 Pm 5.1 Declaration By Dr. Samuel Denmeade
Aug 8, 20252025 08 08 Sanovi Vs. Zentiva Zentiva Counterclaim For Revocation Rule 9 Brief Experts
Aug 7, 2025Anonymized Decision Bis 22248 17.07
Aug 7, 2025Anonymizd Decision 22248 17.07
Jul 17, 2025R 105.5 Rop
Jul 17, 2025Headnote And Keywords
Jul 10, 2025Acknowledgement Of Change Of A Representative
Jul 8, 2025Formal Checks Notification Of Positive Outcome
Jul 8, 2025Exhibit Tw D 17 Signed
Jul 8, 2025Exhibit Tw D 16 Signed
Jul 8, 2025Exhibit Tw D 15 Signed
Jul 8, 2025Exhibit Tw D 14 Signed
Jul 8, 2025Exhibit Dfmp D115 Signed
Jul 8, 2025Exhibit Dfmp D114 Signed
Jul 8, 2025Application Rop293 Receipt
Jul 8, 2025Acknowledgement Of Lodging
Jul 8, 202507 08 Sanovi VS. Zentiva Zentiva Rejoinder Infringement Reply Counterclaim Signed
Jun 27, 2025R 333 Final Signed
Jun 27, 2025Outcome Of The Order
Jun 27, 2025Headnote And Keywords
Jun 27, 2025Application Rop293
Jun 27, 2025Application
Jun 9, 2025Comments
Jun 4, 2025R.333.2.2 Oberservations
Jun 3, 2025Acknowledgement Of Lodging
May 22, 2025Sanofi V Zentiva Zentiva Request For Panel Review
May 22, 2025Exhibit Tw D13 Signed
May 15, 2025Comments
May 14, 2025R 20
May 14, 2025Preliminary Objection Decisionoutcome
May 14, 2025Hearing Reference
May 11, 2025Order 8 May Tailored
May 11, 2025Confidentialty Oberservations
May 9, 2025Headnote And Keywords
May 8, 2025Outcome Of The Order
May 8, 2025Final Order
Apr 9, 2025Exhibit Tw D9 Signed
Apr 9, 2025Exhibit Tw D12B 373 740 Signed
Apr 9, 2025Exhibit Tw D12A 1 372 Signed
Apr 9, 2025Exhibit Tw D11 Signed
Apr 9, 2025Exhibit Tw D10 Signed
Apr 9, 202504 09 Sanofi V Zentiva Zentiva Reply To Sanofi Comments No 2 R. 105 Signed
Mar 21, 2025Outcome Of The Order
Mar 21, 2025262 A Final
Mar 20, 2025Exhibit No. F
Mar 20, 2025Exhibit No. F
Mar 20, 2025Exhibit No. F
Mar 20, 2025Exhibit No. F
Mar 20, 2025Exhibit No. B.01.1.2
Mar 20, 2025Exhibit No. B.01.1
Mar 20, 2025Comments No. 2 Rule 105(5) Rop (Zentiva Unredacted)
Mar 20, 2025Comments No. 2 Rule 105(5) Rop (Zentiva Redacted)
Feb 27, 2025Comments
Feb 13, 2025Receipt
Feb 12, 202502 12 Sanofi VS. Zentiva Zentiva Comment On Order Ord 3586 2025 Application Under R. 263 Rop(.1) Sig
Jan 29, 2025Comments 263 Rop
Jan 27, 2025Final Order R 105.5 Anonymized
Jan 22, 2025Template Order
Jan 22, 2025R 105.5 15 Jan.
Jan 17, 2025R 305 Second Final
Jan 17, 2025Outcome Of The Order
Jan 17, 2025Exhibit No. D04 New Redacted Version
Jan 16, 2025Hearing Reference
Jan 15, 2025App 57840 Upc Cfi 148 262A Anonymized
Jan 14, 2025R 262 A Final
Jan 13, 2025R 305 Second Oral Comments
Jan 13, 2025Hearing Dates
Jan 10, 2025Written Comments
Jan 9, 2025Receipt
Jan 9, 2025R 19 Oral Argument Hearing
Jan 9, 2025Hearing Dates
Jan 9, 2025Exhibit No. A.02
Jan 9, 2025Application
Jan 7, 2025R 305 310 Final
Jan 3, 2025R 262 A Comments
Dec 19, 2024Outcome Of The Order
Dec 19, 2024Extension Request
Dec 13, 2024Reply And Defence
Dec 13, 2024Receipt
Dec 10, 20242024 12 10 Sanofi Vs. Zentiva Zentiva Application Extension Of Deadline Rop 9 334 336
Nov 12, 2024R 37.2 Final Signed
Nov 12, 202411 12 Sanofi VS. Zentiva Zentiva Comment On R.305 Rop Sig
Nov 12, 202411 12 Sanofi VS. Zentiva Zentiva Comment On R.262A Rop Sig
Nov 5, 2024Outcome Of The Order
Nov 5, 2024Comment On Application Rop 262A
Nov 5, 2024Comment Application Rop 305
Nov 4, 2024Receipt
Nov 1, 2024Reply And Defence
Nov 1, 2024Exhibit No. G
Nov 1, 2024Exhibit No. G
Nov 1, 2024Exhibit No. G
Nov 1, 2024Exhibit No. G
Nov 1, 2024Exhibit No. G
Nov 1, 2024Exhibit No. G
Nov 1, 2024Exhibit No. G
Nov 1, 2024Exhibit No. F.01.1 (3)
Nov 1, 2024Exhibit No. F.01.1 (2)
Nov 1, 2024Exhibit No. F.01.1 (1)
Nov 1, 2024Exhibit No. F
Nov 1, 2024Exhibit No. F
Nov 1, 2024Exhibit No. D04 (Unredacted)
Nov 1, 2024Exhibit No. D04 (Redacted)
Nov 1, 2024Exhibit No. D03
Nov 1, 2024Exhibit No. D03
Nov 1, 2024Exhibit No. D01.4 (3)
Nov 1, 2024Exhibit No. D01.4 (2)
Nov 1, 2024Exhibit No. D01.4 (1)
Nov 1, 2024Exhibit No. D01
Nov 1, 2024Exhibit No. B.29 (2)
Nov 1, 2024Exhibit No. B.29 (1)
Nov 1, 2024Exhibit No. B.25 (6)
Nov 1, 2024Exhibit No. B.25 (5)
Nov 1, 2024Exhibit No. B.25 (4)
Nov 1, 2024Exhibit No. B.25 (3)
Nov 1, 2024Exhibit No. B.25 (2)
Nov 1, 2024Exhibit No. B.25 (1)
Nov 1, 2024Exhibit No. B.22
Nov 1, 2024Exhibit No. B.22
Nov 1, 2024Exhibit No. B.22
Nov 1, 2024Exhibit No. B.17
Nov 1, 2024Exhibit No. B.17
Nov 1, 2024Exhibit No. B.16
Nov 1, 2024Exhibit No. B.09
Nov 1, 2024Exhibit No. B.07
Nov 1, 2024Exhibit No. B.07
Nov 1, 2024Exhibit No. B.07
Nov 1, 2024Exhibit No. B.07
Nov 1, 2024Exhibit No. B.07
Nov 1, 2024Exhibit No. B.07
Nov 1, 2024Exhibit No. B.05
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.04
Nov 1, 2024Exhibit No. B.01
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. B
Nov 1, 2024Exhibit No. A
Nov 1, 2024Exhibit No. 0
Nov 1, 2024Application
Nov 1, 2024Acknowledgement Of Lodging
Oct 23, 2024Exhibit No. A.02
Oct 23, 2024Application
Oct 11, 202410 11 Sanofi VS. Zentiva Comment On Response To Preliminary Objection Of 14. July (.1)
Oct 11, 202410 11 Sanofi VS. Zentiva Comment On Procedural Order Of 1 October On Bifurcation(.1)
Oct 10, 2024Comments On Bifurcation
Oct 7, 2024Comments On Bifurcation
Oct 1, 2024R 37.2 Comments
Oct 1, 2024R 19 Comments
Sep 16, 2024Scheduling Final
Sep 16, 2024Panel Appointment
Sep 16, 2024Hearing Dates
Sep 13, 2024Comments
Sep 13, 202409 13 Sanofi VS. Zentiva Comment On Preliminary Order Of
Sep 10, 2024Scheduling Comments
Sep 10, 2024Hearing Dates
Sep 3, 2024Formal Checks Notification Of Positive Outcome
Sep 2, 2024Tw D8 De Leaflet Cabazitaxel
Sep 2, 2024Tw D7 De Smpc Cabazitaxel
Sep 2, 2024Tw D6 Fr Leaflet Cabazitaxel
Sep 2, 2024Tw D5 Fr Smpc Cabazitaxel
Sep 2, 2024Tw D4 Ansm Cabazitaxel
Sep 2, 2024Tw D3 Report Eu Commission
Sep 2, 2024Tw D2 Medicines For Europe
Sep 2, 2024Exhibit Tw D8 De Leaflet Cabazitaxel
Sep 2, 2024Exhibit Tw D7 De Smpc Cabazitaxel
Sep 2, 2024Exhibit Tw D6 Fr Leaflet Cabazitaxel
Sep 2, 2024Exhibit Tw D4 Ansm Cabazitaxel
Sep 2, 2024Exhibit Tw D2 Medicines For Europe
Sep 2, 2024Dfmp P7 Priority Document US61 389969
Sep 2, 2024Dfmp P6 Priority Document US61 383933
Sep 2, 2024Dfmp P5 Priority Document US61 369929
Sep 2, 2024Dfmp P4 Priority Document US61 355888
Sep 2, 2024Dfmp P3 Priority Document US61 355834
Sep 2, 2024Dfmp P2 Priority Document US61 293903
Sep 2, 2024Dfmp P1 Priority Document US61 256160
Sep 2, 2024Dfmp D9 Galletti Et Al.
Sep 2, 2024Dfmp D91 Bissery Et Al.
Sep 2, 2024Dfmp D90 Goetz Et Al.
Sep 2, 2024Dfmp D7 Beardsley Et Al.
Sep 2, 2024Dfmp D72 Scher Et Al.
Sep 2, 2024Dfmp D4 Mita Et Al.
Sep 2, 2024Dfmp D3B Further Blog Post By Dr. Mirtsching July 6
Sep 2, 2024Dfmp D3A Blog Post By Dr. Barry Mirtsching 12 October
Sep 2, 2024Dfmp D38 Sanofi Press Release September 17
Sep 2, 2024Dfmp D37 Winquist Et Al.
Sep 2, 2024Dfmp D35 Leaflet Aventis Oncology
Sep 2, 2024Dfmp D2 National Horizon Scanning Centre
Sep 2, 2024Dfmp D29 Tannock Et Al.
Sep 2, 2024Dfmp D26 Attard Et Al.
Sep 2, 2024Dfmp D25 Correspondence Lancet 2011 377 121 122
Sep 2, 2024Dfmp D21 Ema Assessment Report For Jevtana (Cabazitaxel) January 20
Sep 2, 2024Dfmp D1 Sanofi Aventis Xrp6258 Plus Prednisone Compared To Mitoxantrone Plus Prednisone
Sep 2, 2024Dfmp D18 Ema Guideline On The Evaluation Of Anticancer Medicinal Products In Man
Sep 2, 2024Dfmp D15 De Bono Et Al.
Sep 2, 2024Dfmp D14 Fda Label For Docetaxel (Taxotere)
Sep 2, 2024Dfmp D13 Pivot Et Al.
Sep 2, 2024Dfmp D11 Les Echos 22 Dec
Sep 2, 2024Dfmp D113 Us Code Of Federal Regulations Title 21 Chapter I Part 314
Sep 2, 2024Dfmp D112 Excerpt From The Online National Cancer Institute S Drug Dictionary Re. Cabazitaxel
Sep 2, 2024Dfmp D111 Inn Publication
Sep 2, 2024Dfmp D110 Consolidated List Of Documents Epo
Sep 2, 2024Dfmp D10 Sanofi Aventis Press Release 21 December
Sep 2, 2024Dfmp D109 Albarqouni
Sep 2, 2024Dfmp D108 Barraclough And Davis
Sep 2, 2024Dfmp D105 Sava Et Al.
Sep 2, 2024Dfmp D104 Tannock Clin. Oncol. 1996
Sep 2, 2024Dfmp D103 Fossa. Et Al.
Sep 2, 2024Dfmp D102 Tannock Clin. Oncol. 1989
Sep 2, 2024DFMP 1 Confirmation Of Payment Of Court Fees
Sep 2, 2024Acknowledgement Of Lodging
Sep 2, 202409 02 Sanofi VS. Zentiva Statement Of Defence And Counterclaim For Revoc
Jul 14, 2024Written Comments
Jul 14, 2024Exhibit No. E.1
Jul 14, 2024Exhibit No. E.1
Jul 14, 2024Exhibit No. E.1
Jul 14, 2024Exhibit No. E
Jul 14, 2024Exhibit No. E
Jul 14, 2024Exhibit No. E
Jul 14, 2024Exhibit No. E
Jul 14, 2024Exhibit No. E
Jul 14, 2024Exhibit No. E
Jul 14, 2024Exhibit No. E
Jul 14, 2024Commentpreliminaryobjection
Jul 2, 2024Preliminaryobjection
Jul 2, 2024Exhibit Tw D1
Jul 2, 2024240702 Sanofi VS Zentiva Preliminary Objection
Jun 13, 2024Proof Of Service
Jun 13, 2024Notification Of Service
Jun 11, 2024Proof Of Service
Jun 11, 2024Notification Of Service
Jun 6, 2024Proof Of Service
Jun 6, 2024Notification Of Service
Jun 4, 2024Acknowledgement Of Access To Case
Jun 3, 2024Panel Appointment
Jun 3, 2024Acknowledgement Of Access To Case
May 23, 2024Epouploaddocumentsworkflow
May 22, 2024Document From Epo
May 21, 2024Letter For Service
May 16, 2024Receipt
May 16, 2024Panel Appointment
May 16, 2024Formal Checks Notification Of Positive Outcome
May 16, 2024Epo Request For Case Pending
May 14, 2024Statement Of Claim
May 14, 2024Formal Checks Request For Correction
May 14, 2024Exhibit No. D3
May 14, 2024Exhibit No. D2
May 14, 2024Exhibit No. D2
May 14, 2024Exhibit No. D2
May 14, 2024Exhibit No. D1
May 14, 2024Exhibit No. D1
May 14, 2024Exhibit No. D
May 14, 2024Exhibit No. C.1
May 14, 2024Exhibit No. C
May 14, 2024Exhibit No. B.2
May 14, 2024Exhibit No. B.2
May 14, 2024Exhibit No. B.2
May 14, 2024Exhibit No. B.2
May 14, 2024Exhibit No. B.2
May 14, 2024Exhibit No. B.1.1
May 14, 2024Exhibit No. B.1.1
May 14, 2024Exhibit No. B.1
May 14, 2024Exhibit No. B.1
May 14, 2024Exhibit No. B
May 14, 2024Exhibit No. A.1
May 14, 2024Exhibit No. A
May 14, 2024Exhibit No. 0
May 14, 2024Exhibit No. 0
May 14, 2024Exhibit No. 0
May 13, 2024Statement Of Claim
May 13, 2024Exhibit No. D3
May 13, 2024Exhibit No. D2
May 13, 2024Exhibit No. D2
May 13, 2024Exhibit No. D2
May 13, 2024Exhibit No. D1
May 13, 2024Exhibit No. D1
May 13, 2024Exhibit No. D
May 13, 2024Exhibit No. C.1
May 13, 2024Exhibit No. C
May 13, 2024Exhibit No. B.2
May 13, 2024Exhibit No. B.2
May 13, 2024Exhibit No. B.2
May 13, 2024Exhibit No. B.2
May 13, 2024Exhibit No. B.2
May 13, 2024Exhibit No. B.1.1
May 13, 2024Exhibit No. B.1.1
May 13, 2024Exhibit No. B.1
May 13, 2024Exhibit No. B.1
May 13, 2024Exhibit No. B
May 13, 2024Exhibit No. A.1
May 13, 2024Exhibit No. A
May 13, 2024Exhibit No. 0
May 13, 2024Exhibit No. 0
May 13, 2024Exhibit No. 0
May 13, 2024Acknowledgement Of Lodging

More cases involving EP2493466B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
CC_48036/2024Sep 2, 2024Stada Arzneimittel, Stada Nordic, StadapharmSanofi, Sanofi Aventis, Sanofi Aventis Deutschland, Sanofi Aventis France, Sanofi Belgium, Sanofi Mature, Sanofi Produtos Farmaceuticos LDA, Sanofi Winthrop Industrie
CC_49716/2024Sep 2, 2024Zentiva, Zentiva France, Zentiva PharmaSanofi Mature
UPC_CFI_496/2024Sep 2, 2024Stada Arzneimittel, Stada Nordic, StadapharmSanofi, Sanofi AB, Sanofi Aventis, Sanofi Aventis Deutschland, Sanofi Aventis France, Sanofi Belgium, Sanofi Mature, Sanofi Produtos Farmaceuticos LDA, Sanofi Winthrop Industrie

More cases involving Sanofi

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_34318/2025Aug 5, 2025Sanofi Biotechnology -
APP_33251/2025Jul 21, 2025Sanofi Biotechnology -
ORD_33148/2025Jul 17, 2025Sanofi, Sanofi AB, Sanofi Aventis, Sanofi Aventis Deutschland, Sanofi Aventis France, Sanofi Belgium, Sanofi Mature, Sanofi Produtos Farmaceuticos LDA, Sanofi Winthrop IndustrieStada Arzneimittel, Stada Nordic, Stadapharm

More cases involving Zentiva

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_34541/2025Aug 11, 2025Zentiva, Zentiva France, Zentiva Pharma -
APL_24205/2025May 23, 2025Boehringer IngelheimZentiva Portugal
APP_24524/2025May 23, 2025Zentiva, Zentiva France, Zentiva Pharma -